Henrique Queiroga

433 total citations
37 papers, 253 citations indexed

About

Henrique Queiroga is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Henrique Queiroga has authored 37 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Henrique Queiroga's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Colorectal Cancer Treatments and Studies (6 papers). Henrique Queiroga is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Colorectal Cancer Treatments and Studies (6 papers). Henrique Queiroga collaborates with scholars based in Portugal, Brazil and Switzerland. Henrique Queiroga's co-authors include Venceslau Hespanhol, J Marqués, Gabriela Fernandes, Fernando Barata, António Araújo, Marta Soares, José Carlos Machado, Luı́s Cirnes, Natália Martins and Catarina Pereira and has published in prestigious journals such as Cells, Cancers and Journal of Thoracic Oncology.

In The Last Decade

Henrique Queiroga

32 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrique Queiroga Portugal 11 170 122 45 28 26 37 253
Benoît Samson Canada 10 137 0.8× 246 2.0× 35 0.8× 43 1.5× 20 0.8× 22 336
M. Guirado Spain 9 254 1.5× 202 1.7× 37 0.8× 54 1.9× 30 1.2× 24 361
Edith Perez United States 3 100 0.6× 122 1.0× 89 2.0× 17 0.6× 20 0.8× 3 214
C. Le Péchoux France 7 284 1.7× 205 1.7× 30 0.7× 34 1.2× 31 1.2× 34 348
M. Frueh Switzerland 9 189 1.1× 258 2.1× 43 1.0× 41 1.5× 15 0.6× 31 322
Jacky Créquit France 9 306 1.8× 229 1.9× 29 0.6× 39 1.4× 37 1.4× 18 368
G. Perrocheau France 8 84 0.5× 282 2.3× 72 1.6× 27 1.0× 14 0.5× 17 339
Gökhan Uçar Türkiye 11 83 0.5× 136 1.1× 55 1.2× 28 1.0× 35 1.3× 42 254
Élizabeth Fabre-Guillevin France 8 121 0.7× 106 0.9× 37 0.8× 52 1.9× 8 0.3× 18 264
Arthur Géraud France 9 114 0.7× 150 1.2× 41 0.9× 53 1.9× 27 1.0× 25 277

Countries citing papers authored by Henrique Queiroga

Since Specialization
Citations

This map shows the geographic impact of Henrique Queiroga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrique Queiroga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrique Queiroga more than expected).

Fields of papers citing papers by Henrique Queiroga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrique Queiroga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrique Queiroga. The network helps show where Henrique Queiroga may publish in the future.

Co-authorship network of co-authors of Henrique Queiroga

This figure shows the co-authorship network connecting the top 25 collaborators of Henrique Queiroga. A scholar is included among the top collaborators of Henrique Queiroga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrique Queiroga. Henrique Queiroga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freitas, Cláudia, Francisco Veiga, Vanessa Santos, et al.. (2022). Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors. Pulmonology. 30(4). 352–361. 4 indexed citations
2.
Santos, Vanessa, David Araújo, Hélder Novais Bastos, et al.. (2021). Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center. Frontiers in Molecular Biosciences. 8. 639676–639676.
3.
Pereira, Josué, et al.. (2021). Pituitary metastasis unveiling a lung adenocarcinoma. Endocrinology Diabetes and Metabolism Case Reports. 2021. 5 indexed citations
4.
Freitas, Cláudia, Mini E. Jacob, Denisa Mendonça, et al.. (2019). P1.04-59 Modified Glasgow Prognostic Score Predict Survival Among Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors. Journal of Thoracic Oncology. 14(10). S464–S464. 1 indexed citations
5.
Morais, António, et al.. (2019). Venous and Lung Thromboembolism in the Context of Lung Cancer: Clinical Manifestations, Risk Factors and Prognosis. Acta Médica Portuguesa. 32(10). 647–653. 10 indexed citations
6.
Sousa, Catarina, Natália Martins, Gabriela Fernandes, et al.. (2019). Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer. Lung Cancer. PA4684–PA4684. 1 indexed citations
7.
Queiroga, Henrique, et al.. (2017). Spontaneous regression of a pulmonary adenocarcinoma after core needle biopsy. Autopsy and Case Reports. 7(3). 20–25. 11 indexed citations
8.
Fernandes, Gabriela, et al.. (2017). Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population. Archivos de Bronconeumología. 54(1). 10–17. 16 indexed citations
9.
Mello, Ramon Andrade de, F.M. Andrade Pires, Júlio Oliveira, et al.. (2012). EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study. Tumor Biology. 33(6). 2061–2068. 23 indexed citations
10.
Fernandes, Gabriela, et al.. (2012). PET/TC no estadiamento do carcinoma pulmonar de não pequenas células – concordância entre o estadiamento clínico e o patológico. Revista Portuguesa de Pneumologia. 18(3). 109–114. 3 indexed citations
11.
Fernandes, Gabriela, et al.. (2012). Integrated PET/CT in non-small cell lung cancer staging—Clinical and pathological agreement. Revista Portuguesa de Pneumologia. 18(3). 109–114. 4 indexed citations
12.
Morais, António, et al.. (2010). Superior vena cava syndrome as tumour presentation. Revista Portuguesa de Pneumologia. 16(1). 73–88. 1 indexed citations
13.
Queiroga, Henrique, et al.. (2010). Síndroma da veia cava superior como apresentação de neoplasia. Revista Portuguesa de Pneumologia. 16(1). 73–88. 1 indexed citations
15.
Fernandes, Gabriela, et al.. (2006). Non small cell lung cancer – Comparison between clinical and pathological staging. Revista Portuguesa de Pneumologia. 12(4). 337–357. 6 indexed citations
16.
Fernandes, Gabriela, et al.. (2006). Cancro do pulmão de não pequenas células – Comparação entre o estadiamento clínico e o patológico. Revista Portuguesa de Pneumologia. 12(4). 337–357. 3 indexed citations
17.
Sucena, Maria, Gabriela Fernandes, Henrique Queiroga, & Venceslau Hespanhol. (2005). Cancro do pulmão – O que mudou em duas décadas. Revista Portuguesa de Pneumologia. 11(2). 135–154. 4 indexed citations
19.
Queiroga, Henrique. (2005). Factores de prognóstico “clássicos” no cancro do pulmão. Revista Portuguesa de Pneumologia. 11(sup2). 1 indexed citations
20.
Hespanhol, Venceslau, et al.. (1995). Survival predictors in advanced non-small cell lung cancer. Lung Cancer. 13(3). 253–267. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026